Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
October 27, 2015
Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs
L Zhang, Q H Ji, F Ruge, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 25, 2014
Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy
L Zhang, F Grennan-Jones, M S Draman, et al.
Clinical and Experimental Immunology
|
February 17, 2007
Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease
C Baker, L Chang, K A Elsegood, et al.
Alimentary Pharmacology & Therapeutics
|
May 4, 2006
Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease
T J Creed, C S J Probert, M N Norman, et al.
Primary Care Diabetes
|
February 24, 2021
Referral rates of patients with diabetes to secondary care are inversely related to the prevalence of diabetes in each primary care practice and confidence in treatment, not to HbA1c level
Q Z Siah, N H Ubeysekara, P N Taylor, et al.
European Journal of Endocrinology
|
July 23, 2021
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy
L Bartalena, G J Kahaly, L Baldeschi, et al.
Diabetologia
|
April 7, 2010
IFN-gamma and IL-10 islet-antigen-specific T cell responses in autoantibody-negative first-degree relatives of patients with type 1 diabetes
L G Petrich de Marquesini, J Fu, K J Connor, et al.
Diabetologia
|
December 15, 2011
Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes
A R Cooper, S Sebire, A A Montgomery, et al.
Journal of Immunological Methods
|
June 2, 2019
Detecting autoreactive B cells in the peripheral blood of people with type 1 diabetes using ELISpot
W E Powell, S J Hanna, C N Hocter, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 7, 2016
β-cell specific T-lymphocyte response has a distinct inflammatory phenotype in children with Type 1 diabetes compared with adults
S Arif, V B Gibson, V Nguyen, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
The Journal of Clinical Endocrinology and Metabolism
|
October 27, 2015
Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs
L Zhang, Q H Ji, F Ruge, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 25, 2014
Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy
L Zhang, F Grennan-Jones, M S Draman, et al.
Clinical and Experimental Immunology
|
February 17, 2007
Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease
C Baker, L Chang, K A Elsegood, et al.
Alimentary Pharmacology & Therapeutics
|
May 4, 2006
Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease
T J Creed, C S J Probert, M N Norman, et al.
Primary Care Diabetes
|
February 24, 2021
Referral rates of patients with diabetes to secondary care are inversely related to the prevalence of diabetes in each primary care practice and confidence in treatment, not to HbA1c level
Q Z Siah, N H Ubeysekara, P N Taylor, et al.
European Journal of Endocrinology
|
July 23, 2021
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy
L Bartalena, G J Kahaly, L Baldeschi, et al.
Diabetologia
|
April 7, 2010
IFN-gamma and IL-10 islet-antigen-specific T cell responses in autoantibody-negative first-degree relatives of patients with type 1 diabetes
L G Petrich de Marquesini, J Fu, K J Connor, et al.
Diabetologia
|
December 15, 2011
Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes
A R Cooper, S Sebire, A A Montgomery, et al.
Journal of Immunological Methods
|
June 2, 2019
Detecting autoreactive B cells in the peripheral blood of people with type 1 diabetes using ELISpot
W E Powell, S J Hanna, C N Hocter, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 7, 2016
β-cell specific T-lymphocyte response has a distinct inflammatory phenotype in children with Type 1 diabetes compared with adults
S Arif, V B Gibson, V Nguyen, et al.
Page
of 7